Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shan Su

Showing results (261-270 of 274) with videos related to

Pageof 28
Sort By:
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|July 6, 2026
Agmatine induces mitophagy via the PTS-I2R pathway to increase autophagic flux and attenuate sepsis-induced intestinal epithelial cell apoptosisHe Jin, Shuangqin Yin, Yongming Li, et al.
Chemical Communications (Cambridge, England)|January 18, 2022
Neutralizing SARS-CoV-2 by dimeric side chain-to-side chain cross-linked ACE2 peptide mimeticsYan-Ni Zhang, Yuwei Zhang, Shan Su, et al.
Communications Biology|June 1, 2023
A spike-targeting bispecific T cell engager strategy provides dual layer protection against SARS-CoV-2 infection in vivoFanlin Li, Wei Xu, Xiaoqing Zhang, et al.
Medcomm|March 12, 2024
Hypoxia-activated ADCC-enhanced humanized anti-CD147 antibody for liver cancer imaging and targeted therapy with improved selectivityFang-Zheng Qi, Hui-Shan Su, Bo Wang, et al.
Annals of Translational Medicine|November 26, 2020
Efficacy and safety of concurrent anti-tuberculosis treatment and chemotherapy in lung cancer patients with co-existent tuberculosisMei-Feng Ye, Shan Su, Zhi-Hao Huang, et al.
Plos One|March 15, 2018
Identification of race-associated metabolite biomarkers for hepatocellular carcinoma in patients with liver cirrhosis and hepatitis C virus infectionCristina Di Poto, Shisi He, Rency S Varghese, et al.
BMC Medicine|December 20, 2021
Assessment of anti-PD-(L)1 for patients with coexisting malignant tumor and tuberculosis classified by active, latent, and obsolete stageShan Su, Mei-Feng Ye, Xiao-Ting Cai, et al.
Biomed Research International|November 30, 2019
Tumor Mutational Burden and Genomic Alterations in Chinese Small Cell Lung Cancer Measured by Whole-Exome SequencingShan Su, Jian-Jun Zou, Yun-Yun Zeng, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 26, 2023
Incidence of Childhood Type 1 Diabetes in Beijing During 2011-2020 and Predicted Incidence for 2025-2035: A Multicenter, Hospitalization-Based StudyYuchuan Li, Kun Qian, Di Wu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 30, 2018
Strong Programmed Death Ligand 1 Expression Predicts Poor Response and De Novo Resistance to EGFR Tyrosine Kinase Inhibitors Among NSCLC Patients With EGFR MutationShan Su, Zhong-Yi Dong, Zhi Xie, et al.
Pageof 28

Showing results (261-270 of 274) with videos related to

Sort By:
Pageof 28
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|July 6, 2026
Agmatine induces mitophagy via the PTS-I2R pathway to increase autophagic flux and attenuate sepsis-induced intestinal epithelial cell apoptosisHe Jin, Shuangqin Yin, Yongming Li, et al.
Chemical Communications (Cambridge, England)|January 18, 2022
Neutralizing SARS-CoV-2 by dimeric side chain-to-side chain cross-linked ACE2 peptide mimeticsYan-Ni Zhang, Yuwei Zhang, Shan Su, et al.
Communications Biology|June 1, 2023
A spike-targeting bispecific T cell engager strategy provides dual layer protection against SARS-CoV-2 infection in vivoFanlin Li, Wei Xu, Xiaoqing Zhang, et al.
Medcomm|March 12, 2024
Hypoxia-activated ADCC-enhanced humanized anti-CD147 antibody for liver cancer imaging and targeted therapy with improved selectivityFang-Zheng Qi, Hui-Shan Su, Bo Wang, et al.
Annals of Translational Medicine|November 26, 2020
Efficacy and safety of concurrent anti-tuberculosis treatment and chemotherapy in lung cancer patients with co-existent tuberculosisMei-Feng Ye, Shan Su, Zhi-Hao Huang, et al.
Plos One|March 15, 2018
Identification of race-associated metabolite biomarkers for hepatocellular carcinoma in patients with liver cirrhosis and hepatitis C virus infectionCristina Di Poto, Shisi He, Rency S Varghese, et al.
BMC Medicine|December 20, 2021
Assessment of anti-PD-(L)1 for patients with coexisting malignant tumor and tuberculosis classified by active, latent, and obsolete stageShan Su, Mei-Feng Ye, Xiao-Ting Cai, et al.
Biomed Research International|November 30, 2019
Tumor Mutational Burden and Genomic Alterations in Chinese Small Cell Lung Cancer Measured by Whole-Exome SequencingShan Su, Jian-Jun Zou, Yun-Yun Zeng, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 26, 2023
Incidence of Childhood Type 1 Diabetes in Beijing During 2011-2020 and Predicted Incidence for 2025-2035: A Multicenter, Hospitalization-Based StudyYuchuan Li, Kun Qian, Di Wu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 30, 2018
Strong Programmed Death Ligand 1 Expression Predicts Poor Response and De Novo Resistance to EGFR Tyrosine Kinase Inhibitors Among NSCLC Patients With EGFR MutationShan Su, Zhong-Yi Dong, Zhi Xie, et al.
Pageof 28